Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
3.670
+0.080 (2.23%)
Sep 30, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1362296711745148
Market Cap Growth
27.68%241.56%-42.84%161.30%-69.80%165.90%
Enterprise Value
42639219020759149
Last Close Price
3.676.281.853.241.245.48

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
24.6246.6212.9425.868.1433.18
PB Ratio
--1.05-1.39-3.651.245.85
P/TBV Ratio
----1.386.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
76.9479.8536.7545.6610.6933.23

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.36-1.32-2.63-3.751.351.50
Net Debt / Equity Ratio
-1.25-1.28-2.44-3.330.941.09
Net Debt / EBITDA Ratio
-8.67-9.41-2.85-2.68-0.94-1.22
Net Debt / FCF Ratio
-11.24-10.62-2.97-1.92-0.98-1.11
Asset Turnover
0.070.060.060.050.070.08
Quick Ratio
0.111.020.211.030.942.76
Current Ratio
0.111.190.231.161.093.12
Return on Equity (ROE)
----3439.35%-120.10%-104.65%
Return on Assets (ROA)
-25.83%-23.90%-28.70%-26.32%-27.89%-27.25%
Return on Capital Employed (ROCE)
22.00%-46.00%-111.10%-49.90%-52.10%-36.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-140.83%-76.02%-28.26%-58.95%-82.37%-15.60%
FCF Yield
-18.90%-11.51%-58.90%-47.45%-77.40%-16.76%
Buyback Yield / Dilution
-0.77%38.64%-63.71%-5.20%-42.27%-46.84%
SEC Filings: 10-K · 10-Q